LIVE MARKET TRACKER :   BSE SENSEX   33462.97      |    NSE NIFTY 10333.25    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Biocon shines on launching KRABEVA for treating several types of cancer in India

Biocon shines on launching KRABEVA for treating several types of cancer in India (23-Nov-2017)

Biocon is currently trading at Rs. 417.70, up by 9.10 points or 2.23% from its previous closing of Rs. 408.60 on the BSE.

The scrip opened at Rs. 410.00 and has touched a high and low of Rs. 418.60 and Rs. 405.80 respectively. So far 189404 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 427.95 on 21-Nov-2017 and a 52 week low of Rs. 280.39 on 23-Nov-2016.

Last one week high and low of the scrip stood at Rs. 427.95 and Rs. 379.15 respectively. The current market cap of the company is Rs. 25089.00 crore.

The promoters holding in the company stood at 60.67%, while institutions and non-institutions held 19.23% and 20.10% respectively.

Biocon has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian and brain cancers, in India.

KRABEVA, a monoclonal antibody (mAb) developed by Biocon, will help expand access to a world class, high quality biosimilar Bevacizumab for cancer patients in India. It is the world's first and only Bevacizumab with a unique 'Qual-Check' mechanism, which will ensure that patients get a quality-ascertained product right upto infusion.

Bevacizumab is indicated as a first-line treatment of patients with metastatic colorectal cancer (mCRC), and is accepted as a standard treatment option in combination with chemotherapy for patients with non-small-cell lung cancer (NSLC), metastatic renal cell carcinoma and recurrent ovarian cancer.

Biocon is India's largest and Asia's leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Top News Today
Petronet executes revised commercial understanding for purchase of LNG from Mobil Australia
(16-Dec-2017)

Petronet executes revised commercial understanding for purchase of LNG from Mobil AustraliaPetronet LNG has executed the relevant agreements to record the revised commercial understanding on the agreement for purchase of 1.44 MTPA of LNG from Mobil Australia Resources Company (LNG Supplier),......click on news to read complete article.

Asian Granito to give corporate guarantee of Rs 2.5 crore in favor of Camrola Quartz
(16-Dec-2017)

Asian Granito to give corporate guarantee of Rs 2.5 crore in favor of Camrola QuartzAsian Granito India has received an approval to give the Corporate Guarantee of Rs 2.5 crore in favor of Camrola Quartz, subsidiary of the company. The Administrative Committee of the company in its meeting......click on news to read complete article.

Tinna Rubber gets NCLT's nod for composite scheme of arrangement
(16-Dec-2017)

Tinna Rubber gets NCLTTinna Rubber and Infrastructure has received National Company Law Tribunal's (NCLT) approval for the Composite Scheme of Arrangement between the company and Tinna Trade and their respective shareholders......click on news to read complete article.

International Stock News
US markets closed higher on tax-cut optimism
(16-Dec-2017)

US markets closed higher on tax-cut optimismThe US markets closed higher on Friday and booked weekly gains, as investor expectations grew for passage of Republican-backed tax-cut legislation. Politics surrounding the tax bill continued to influence......click on news to read complete article.

Asian markets trade mostly in red in early deals on Friday
(15-Dec-2017)

Asian markets trade mostly in red in early deals on FridayMost of the Asian equity benchmarks are trading in red in the early deals on Friday with the overnight weak close on Wall Street amid uncertainty about the outlook for the Republican tax reform plan weighing......click on news to read complete article.

US markets closed lower on Thursday
(15-Dec-2017)

US markets closed lower on ThursdayThe US markets closed lower on Thursday, with the selling pressure coming from health-care, materials sectors and telecoms sectors. Details of the Republican tax deal have started to trickle out, with......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.